4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000307
Director sold 1,048,067 shares at an average $11.50 ($12,053,730)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2018-03-27 | Sale | −1,016,084 | $11.50 | $11,684,966 | 5,133,293 | I: show line 1 in the form |
| ORBIMED ADVISORS LLC Director | 2018-03-29 | Sale | −31,983 | $11.53 | $368,764 | 5,101,310 | I: show line 2 in the form |
| Open-market sales · 1,048,067 sh · avg $11.50 · $12,053,730 | |||||||
Loading xslF345X03/ss86018_4.xml…